Product Description
We have been setting benchmarks of success in the market as a prominent organization engaged in offering Bondronat Tablet. The tablet is indicated in adults for the prevention of skeletal events such as pathological fractures and bone complications. Each film-coated tablet contains 50 mg of ibandronic acid. We source this tablet from trusted vendors of the market. Bondronat Tablet is also prescribed to patients with breast cancer and bone metastases.
Features:
- Prevents bones from breaking
- Extended shelf life
- Low indication of side effects
Specifications:
- Content: Ibandronic Acid
- Form: Tablet
- Strength: 50 mg
- Packing: Pack Of 28 Tabs
- Available as: 50 mg Tablets
- Manufactured by: Roche
Features of Bondronat TabletBondronat Tablet offers a convenient once-monthly dosing for patients requiring osteoporosis or bone metastases management. Its formulation combines Ibandronic Acid with supporting excipients to assist in maintaining bone density and lowering fracture risk, making it suitable for long-term therapy under medical supervision.
Proper Usage InstructionsBondronat should be taken orally with plain water, and the tablet must be swallowed whole without crushing or chewing. This ensures optimal absorption and reduces gastrointestinal discomfort. Its vital to adhere to the prescribed schedule and consult your doctor if you need any adjustment or experience side effects.
Storage and Handling GuidelinesTo maintain the efficacy and safety of Bondronat Tablet, keep it in its original blister packaging, stored below 30C in a cool, dry place. Do not transfer tablets to other containers. Always check the package for expiry before use and keep it out of reach of children.
FAQs of Bondronat Tablet:
Q: How should Bondronat Tablet be administered for best results?
A: Bondronat Tablet should be swallowed whole with water, preferably at the same time each month, without chewing or crushing. Taking it on an empty stomach improves absorption.
Q: What are the main benefits of using Bondronat Tablet?
A: Bondronat helps to strengthen bones, manage osteoporosis in postmenopausal women, and treat metastatic bone disease, reducing the risk of fractures with convenient once-monthly dosing.
Q: When is Bondronat indicated for use?
A: Bondronat is prescribed for postmenopausal osteoporosis and metastatic bone disease, following a doctors assessment. It is intended for patients who require long-term bone-strengthening treatment.
Q: Where should I store my Bondronat Tablets to ensure they remain effective?
A: Keep Bondronat Tablets in their original blister packaging, stored below 30C in a cool, dry place, away from direct light or moisture, and out of reach of children.
Q: What precautions should I follow during the course of Bondronat Tablet?
A: Bondronat should not be used in individuals with hypocalcemia or severe renal impairment. Follow usage instructions and inform your doctor of any side effects or changes in medical condition.
Q: What is the process for obtaining Bondronat Tablet?
A: Bondronat Tablet is only available with a valid prescription and can be bought from pharmacies in India distributed, exported, or traded by authorized channels.